NICE has developed a medtech innovation briefing (MIB) on the Juxta CURES adjustable compression system for treating venous leg ulcers.
The Juxta CURES is an adjustable wrap-around compression system for use in patients with venous leg ulcers in whom compression therapy is otherwise indicated. The Juxta CURES is designed to be easier to apply than standard compression bandages, is guaranteed for 6 months of daily use and can be prescribed using an FP10 prescription. After initial fitting by a trained clinician, the Juxta CURES can be adjusted by a clinician, patient or carer. The level of pressure applied is measurable and adjustable due to a built-in pressure system.
Medtech innovation briefings provide a description of the medical technology, including its likely place in therapy, the costs of using the technology and a critical review of the strengths and weaknesses of the relevant published evidence.
Their purpose is to provide objective information on device and diagnostic technologies to aid local decision-making by clinicians, managers and procurement professionals. By making this information available, NICE helps to avoid the need for NHS organisations to produce similar information for local use.
Medtech innovation briefings are not NICE guidance. They differ in format, contain no judgement on the value of the technology and do not constitute a guidance recommendation.
MIBs are commissioned by NHS England and produced in support of the NHS 5 Year Forward View, specifically as one of a number of steps which will accelerate innovation in new treatments and diagnostics.